We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRH icon
351
CRH
CRH
$66.8B
$700K 0.07%
7,620
+1,755
+30% +$160K
XPRO icon
352
Expro Ltd
XPRO
$1.91B
$699K 0.07%
81,427
+4,326
+6% +$36.7K
COKE icon
353
Coca-Cola Consolidated
COKE
$12.8B
$696K 0.07%
6,231
-409
-6% -$49.4K
SLGN icon
354
Silgan Holdings
SLGN
$4.41B
$695K 0.07%
+12,834
New +$679K
KVYO icon
355
Klaviyo
KVYO
$4.73B
$692K 0.07%
20,614
+7,624
+59% +$242K
ETNB
356
DELISTED
89bio
ETNB
$691K 0.07%
70,387
-27,700
-28% -$229K
DLB icon
357
Dolby
DLB
$5.79B
$690K 0.07%
+9,296
New +$696K
VSXY
358
Victoria's Secret
VSXY
$7.83B
$680K 0.07%
36,693
+26,668
+266% +$521K
GSY icon
359
Invesco Ultra Short Duration ETF
GSY
$3.88B
$676K 0.07%
+13,490
New +$676K
RGNX icon
360
Regenxbio
RGNX
$708M
$676K 0.07%
82,321
-30,199
-27% -$253K
LPG icon
361
Dorian LPG
LPG
$1.96B
$673K 0.07%
27,611
-4,995
-15% -$111K
FTAI icon
362
FTAI Aviation
FTAI
$22.2B
$666K 0.06%
5,785
+3,875
+203% +$433K
GAP
363
The Gap Inc
GAP
$7.37B
$665K 0.06%
+30,488
New +$681K
EWY icon
364
iShares MSCI South Korea ETF
EWY
$25.7B
$664K 0.06%
9,250
-55
-0.6% -$3.3K
CNTA
365
DELISTED
Centessa Pharmaceuticals
CNTA
$658K 0.06%
50,100
+14,300
+40% +$181K
RKLB icon
366
Rocket Lab Corp
RKLB
$51.8B
$653K 0.06%
+18,253
New +$447K
COR icon
367
Cencora
COR
$61.2B
$644K 0.06%
2,149
+871
+68% +$251K
INTR icon
368
Inter&Co
INTR
$2.33B
$639K 0.06%
86,000
-29,000
-25% -$193K
BRK.B icon
369
Berkshire Hathaway Class B
BRK.B
$1.13T
$638K 0.06%
+1,314
New +$667K
TGNA
370
DELISTED
TEGNA Inc
TGNA
$638K 0.06%
38,077
+126
+0.3% +$2.1K
LNG icon
371
Cheniere Energy
LNG
$52.9B
$637K 0.06%
2,615
-12,590
-83% -$2.92M
KBR icon
372
KBR
KBR
$4.8B
$635K 0.06%
+13,245
New +$687K
RPD icon
373
Rapid7
RPD
$773M
$633K 0.06%
27,371
-298
-1% -$7.07K
CLDX icon
374
Celldex Therapeutics
CLDX
$3.28B
$632K 0.06%
+31,066
New +$605K
GNK icon
375
Genco Shipping & Trading
GNK
$1.1B
$632K 0.06%
+48,322
New +$639K
13 14
15
16 17

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.